This is the first update to the original CTS communication distributed on July 6th. As previously communicated, all CTS healthcare partners will remain on the Grifols ZIKV clinical trial until at least the end of October 2018, which coincides with the end of the WNV season.
Check out the Communication page for the complete details on the NAT ZIKV test update or by clicking the link: Communications
On September 14, 2020, our Phoenix laboratory began performing a portion of our alternate donor anti...
CTS Charlotte Lab successfully implemented WNV NAT testing on the Panther Testing Platform on Monday...
The CTS 2020 Annual Laboratory Survey is on its way to your email box. We would appreciate you takin...
The COVID-19 pandemic has unveiled the huge challenges and risks health workers are facing globally ...
CTS received notification from Sanochemia Pharmazeutika AG of their intent to immediately discontinu...
TEMPE, Ariz. (Sept. 8, 2022) — Marion Lanteri, Ph.D., began this week as Creative Testing Solu...